Результаты поиска

[Results of treatment of acute uncomplicated cystitis in 440 women of working age in a large industrial city].

INTRODUCTION: Lower urinary tract infections (UTIs) affect nearly two-thirds of all women during their lifetime, and many suffer from recurr … al remedies. In the group 2, drotaverine was used at 80 mg 3 times a day for 2 days, in the group 3 phenazopyridine at a dose of 200 mg 3 times a day for 2 days was given, while in the group 4, Canephron N at 2 tablets 3 times a day for 6 days was administered. The symptoms of cystitis were assessed using the ACSS scale, visual analog scale (VAS) of pain, urinaly …

Interstitial cystitis/painful bladder syndrome.

Interstitial cystitis (IC) is a chronic, painful bladder syndrome primarily found in women. Although the direct cause(s) of IC are unknown, several theories exist. Common symptoms include urinary urgency, frequency, and pain. Treatment options include behavioral therapies, use of pharmacologic agents, and surgery. Patients benefit from prompt diagnosis and initiation of treatments. Important clinical features of IC in women including the pathology, common symptoms, and recommended evaluation and management strategies are reviewed.

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

PURPOSE: To assess the urinary morbidity experienced by patients undergoing ultrasound-guided, permanent transperineal seed implantation for … xicity was symptomatic nocturia or frequency requiring none or minimal medical intervention such as phenazopyridine; grade 2 urinary toxicity was early obstructive symptomatology requiring alpha-blocker therapy; and grade 3 toxicity was considered that requiring indwelling catheters or posttreatment transurethral resection of the prostate for symptom relief. Log- …

Acute interstitial nephritis - a reappraisal and update.

Acute interstitial nephritis (AIN) is an under recognized and under diagnosed cause of acute kidney injury (AKI). It is estimated to account for 15 - 20% of cases of AKI; it is the reported diagnosis in 2.8% of all kidney biopsies, and 13.5% of biopsies done specifically for acute renal failure. Considerable evidence implicates antigen initiated cell-mediated injury in the pathogenesis of AIN. Drugs account for 70% of all cases, with over 150 different agents incriminated. The remaining cases are due to infections, autoimmune diseases, and rarely idiopathic. The central component of renal inju

Совпадение в полном тексте источника
… clomipramine, cocaine, creatine monohydrate, deferasirox, diltiazem, diphenadione, ergotamine, etanercept, exenatide, fluindione, foscarnet, hydroxyethyl starch, interleukin, isotretinoin, immunoglobulin, griseofulvin, kudzu root juice, levetiracetam, liraglutide, methyldopa, paraphenylene diamine, phenazopyridine … clomipramine, cocaine, creatine monohydrate, deferasirox, diltiazem, diphenadione, ergotamine, etanercept, exenatide, fluindione, foscarnet, hydroxyethyl starch, interleukin, isotretinoin, immunoglobulin, griseofulvin, kudzu root juice, levetiracetam, liraglutide, methyldopa, paraphenylene diamine, phenazopyridine …

Repurposing FDA approved drugs as possible anti-SARS-CoV-2 medications using ligand-based computational approaches: sum of ranking difference-based model selection.

The worldwide burden of coronavirus disease 2019 (COVID-19) is still unremittingly prevailing, with more than 440 million infections and over 5.9 million deaths documented so far since the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic. The non-availability of treatment further aggravates the scenario, thereby demanding the exploration of pre-existing FDA-approved drugs for their effectiveness against COVID-19. The current research aims to identify potential anti-SARS-CoV-2 drugs using a computational approach and repurpose them if possible. In the present study, we have

Совпадение в полном тексте источника
… The higher the number of this fragment, the lower will be the antiviral activity, as observed in Phenazopyridine (compound 13 ) and Gliteritinib (compound 38 ). These two compounds contain two and one -NH 2 fragment, respectively, and have antiviral activity in the lower range. …

15th Report on Carcinogens.

BACKGROUND: The Report on Carcinogens (RoC) is a congressionally mandated, science-based public health document that the National Toxicology … roducts of Its Synthesis; Phenacetin (see Phenacetin and Analgesic Mixtures Containing Phenacetin); Phenazopyridine Hydrochloride; Phenolphthalein; Phenoxybenzamine Hydrochloride; Phenytoin and Phenytoin Sodium; Polybrominated Biphenyls; Polychlorinated Biphenyls; Procarbazine and Its Hydrochloride; Progesterone; 1,3-Propane Sultone; β-Propiolactone; Propylene Ox …

Infectious Diseases

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… macrocrystals 100 mg PO qhs ×6 months), post-coital prophylaxis ( trimethoprim–sulfamethoxazole DS ½-1 tab PO post-coital, nitrofurantoin 50 mg PO or macrocrystals 100 mg PO post-coital), patient-initiated treatment (start standard dose of antibiotics with onset of UTI symptoms) SYMPTOM CONTROL — phenazopyridine …

Infectious Diseases

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… macrocrystals 100 mg PO qhs × 6 months), postcoital prophylaxis ( trimethoprim – sulfamethoxazole DS ½-1 tab PO post-coital, nitrofurantoin 50 mg PO or macrocrystals 100 mg PO post-coital), patient - initiated treatment (start standard dose of antibiotics with onset of UTI symptoms) SYMPTOM CONTROL — phenazopyridine …

Haematological Diseases in the Tropics

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Резюме докладов 38th - ежегодное собрание общества общей внутренней медицины.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Р

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Emergency Care

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Abstracts from the 37th Annual Meeting of the Society of General Internal Medicine, 2014, San Diego, CA, USA.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Резюме докладов 2017 Ежегодное совещание Общества общей внутренней медицины.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.